Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1
- PMID: 8196635
- PMCID: PMC358762
- DOI: 10.1128/mcb.14.6.3960-3970.1994
Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1
Abstract
The human immunodeficiency virus type 1 (HIV-1) RNA follows a complex splicing pathway in which a single primary transcript either remains unspliced or is alternatively spliced to more than 30 different singly and multiply spliced mRNAs. We have used an in vitro splicing assay to identify cis elements within the viral genome that regulate HIV-1 RNA splicing. A novel splicing regulatory element (SRE) within the first tat coding exon has been detected. This element specifically inhibits splicing at the upstream 3' splice site flanking this tat exon. The element only functions when in the sense orientation and is position dependent when inserted downstream of a heterologous 3' splice site. In vivo, an HIV-1 SRE mutant demonstrated a decrease in unspliced viral RNA, increased levels of single- and double-spliced tat mRNA, and reduced levels of env and rev mRNAs. In addition to the negative cis-acting SRE, the flanking 5' splice site downstream of the first tat coding exon acts positively to increase splicing at the upstream 3' splice sites. These results are consistent with hypotheses of bridging interactions between cellular factors that bind to the 5' splice site and those that bind at the upstream 3' splice site.
Similar articles
-
Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.J Virol. 1999 Dec;73(12):9764-72. doi: 10.1128/JVI.73.12.9764-9772.1999. J Virol. 1999. PMID: 10559286 Free PMC article.
-
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.Mol Cell Biol. 1995 Aug;15(8):4606-15. doi: 10.1128/MCB.15.8.4606. Mol Cell Biol. 1995. PMID: 7623852 Free PMC article.
-
The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.Mol Cell Biol. 1998 Sep;18(9):5404-13. doi: 10.1128/MCB.18.9.5404. Mol Cell Biol. 1998. PMID: 9710624 Free PMC article.
-
HIV-1: To Splice or Not to Splice, That Is the Question.Viruses. 2021 Jan 26;13(2):181. doi: 10.3390/v13020181. Viruses. 2021. PMID: 33530363 Free PMC article. Review.
-
Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication.Adv Virus Res. 2009;74:1-40. doi: 10.1016/S0065-3527(09)74001-1. Adv Virus Res. 2009. PMID: 19698894 Review.
Cited by
-
The strength of the HIV-1 3' splice sites affects Rev function.Retrovirology. 2006 Dec 4;3:89. doi: 10.1186/1742-4690-3-89. Retrovirology. 2006. PMID: 17144911 Free PMC article.
-
Human immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polypyrimidine tracts.Mol Cell Biol. 2003 Dec;23(23):8762-72. doi: 10.1128/MCB.23.23.8762-8772.2003. Mol Cell Biol. 2003. PMID: 14612416 Free PMC article.
-
An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.J Virol. 2005 Aug;79(16):10478-86. doi: 10.1128/JVI.79.16.10478-10486.2005. J Virol. 2005. PMID: 16051840 Free PMC article.
-
A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14088-93. doi: 10.1073/pnas.95.24.14088. Proc Natl Acad Sci U S A. 1998. PMID: 9826658 Free PMC article.
-
Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant.J Virol. 1996 Jun;70(6):3636-44. doi: 10.1128/JVI.70.6.3636-3644.1996. J Virol. 1996. PMID: 8648698 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources